CTOs on the Move

Florida Blue

www.bcbsfl.com

 
Florida Blue is a subsidiary of a not-for-profit health solutions company dedicated to serving all Floridians in the pursuit of health. Florida Blue is an independent licensee of the Blue Cross and Blue Shield Association, serving residents and businesses in the state of Florida.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.bcbsfl.com
  • 4800 Deerwood Campus Pkwy
    Jacksonville, FL USA 32246-6498
  • Phone: 904.791.6111

Executives

Name Title Contact Details
Ken Morris
Director - Information & Cyber Security (Interim CISO) Profile

Similar Companies

Extend Fertility

Extend Fertility is the first service in the U.S. focused exclusively on women who want to proactively preserve their fertility options.

Abkit

Abkit Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nueterra

Nueterra Capital is a private equity investment and advisory firm with an exclusive focus on healthcare. Leveraging a deep understanding of key industry drivers, Nueterra Capital invests in entrepreneurs with innovative minds, while providing professional expertise and back office resources to improve their bottom line performance and drive growth. Nueterra Capital has invested in hundreds of new ventures and continuously delivers the resources and strategic direction that allow our partners to advance and improve every aspect of healthcare.

Advantedge Healthcare Solutions

Advantedge Healthcare Solutions (AHS) was founded in 1999 by long-time veterans of the healthcare information technology industry. We proudly serve specialty physicians with the latest RCM services and billing software.

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.